| 000 | 01500 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513062759.0 | ||
| 264 | 0 | _c19940503 | |
| 008 | 199405s 0 0 eng d | ||
| 022 | _a0036-8075 | ||
| 024 | 7 |
_a10.1126/science.8146663 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEtcheberrigaray, R | |
| 245 | 0 | 0 |
_aSoluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cApr 1994 |
||
| 300 |
_a276-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xpharmacology |
| 650 | 0 | 4 |
_aBombesin _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDimethyl Sulfoxide _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPotassium Channel Blockers |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 |
_aPotassium Chloride _xpharmacology |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTetraethylammonium |
| 650 | 0 | 4 |
_aTetraethylammonium Compounds _xpharmacology |
| 700 | 1 | _aIto, E | |
| 700 | 1 | _aKim, C S | |
| 700 | 1 | _aAlkon, D L | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 264 _gno. 5156 _gp. 276-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.8146663 _zAvailable from publisher's website |
| 999 |
_c8145987 _d8145987 |
||